- Home
- VIR vs NAK Comparison
VIR vs NAK Comparison
Compare VIR & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- NAK
- Stock Information
- Founded
- VIR 2016
- NAK 1983
- Country
- VIR United States
- NAK Canada
- Employees
- VIR N/A
- NAK N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- NAK Precious Metals
- Sector
- VIR Health Care
- NAK Basic Materials
- Exchange
- VIR Nasdaq
- NAK Nasdaq
- Market Cap
- VIR 706.4M
- NAK 725.3M
- IPO Year
- VIR 2019
- NAK 2002
- Fundamental
- Price
- VIR $5.65
- NAK $0.89
- Analyst Decision
- VIR Strong Buy
- NAK Strong Buy
- Analyst Count
- VIR 8
- NAK 1
- Target Price
- VIR $30.25
- NAK $2.50
- AVG Volume (30 Days)
- VIR 1.2M
- NAK 28.4M
- Earning Date
- VIR 08-04-2025
- NAK 08-14-2025
- Dividend Yield
- VIR N/A
- NAK N/A
- EPS Growth
- VIR N/A
- NAK N/A
- EPS
- VIR N/A
- NAK N/A
- Revenue
- VIR $20,861,000.00
- NAK N/A
- Revenue This Year
- VIR N/A
- NAK N/A
- Revenue Next Year
- VIR $0.62
- NAK N/A
- P/E Ratio
- VIR N/A
- NAK N/A
- Revenue Growth
- VIR N/A
- NAK N/A
- 52 Week Low
- VIR $4.32
- NAK $0.30
- 52 Week High
- VIR $14.45
- NAK $2.40
- Technical
- Relative Strength Index (RSI)
- VIR 54.74
- NAK 34.68
- Support Level
- VIR $5.31
- NAK $0.87
- Resistance Level
- VIR $5.92
- NAK $1.00
- Average True Range (ATR)
- VIR 0.30
- NAK 0.26
- MACD
- VIR 0.02
- NAK -0.14
- Stochastic Oscillator
- VIR 43.69
- NAK 6.21
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About NAK Northern Dynasty Minerals Ltd.
Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.